Clinical Gastroenterology and Hepatology ( IF 12.6 ) Pub Date : 2020-01-23 , DOI: 10.1016/j.cgh.2020.01.018 Ming-Ling Chang , Jur-Shan Cheng , Rong-Nan Chien , Yun-Fan Liaw
Background & Aims
Little is known about the effects of baseline hepatitis flares (level of alanine aminotransferase ≥5-fold above the upper limit of normal) on the outcomes of patients with chronic hepatitis B virus (HBV) infection with decompensated cirrhosis treated with nucleos(t)ide analogues. We aimed to investigate these effects.
Methods
We performed a cohort study of 511 consecutive patients (78.1% men; 58.7% with flares at baseline) with chronic HBV infection and decompensated cirrhosis who were treated with nucleos(t)ide analogues as soon as decompensation was noted. Patients were enrolled from January 2002 to March 2018 at a tertiary care center in Taiwan and followed up for 16 years.
Results
Patients with hepatitis flares had higher mean baseline levels of HBV DNA (6.44 ± 1.52 vs 6.08 ± 1.46 log10 IU/mL; P = .003), hepatitis B surface antigen, and total bilirubin; prolonged prothrombin time; higher platelet counts (108.0 ± 42.9 vs 83.6 ± 44.7 103/μL; P < .001); and a higher proportion were infected with HBV genotype B, compared with patients without flares. Patients with flares had lower ratios of neutrophils to lymphocytes than patients with flares (6.14 ± 9.18 vs 9.12 ± 1.36; P = .019); were less likely than patients without flares to be positive for hepatitis B e antigen, ascites, esophageal varices, or splenomegaly; and a lower proportion died or underwent liver transplantation (46.5% vs 73.2% of patients without flares; P < .001), even though the patients without flares had similar short-term (<3 mo) outcomes. Factors associated independently with baseline flares were esophageal varices (odds ratio [OR], 0.165; 95% CI, 0.067–0.406), ascites (OR, 0.415; 95% CI, 0.178–0.969), levels of total bilirubin (OR, 1.158; 95% CI, 1.041–1.269), prolonged prothrombin time (OR, 1.095; 95% CI, 1.033–1.168), and higher platelet counts (OR, 1.009; 95% CI, 1.00–1.018). After we used propensity score matching to match patients with and without baseline flares, factors associated with the cumulative incidence of death or liver transplantation were flares (hazard ratio [HR], 0.491; 95% CI, 0.317–0.76), ratio of neutrophils to lymphocytes (HR, 1.278; 95% CI, 1.027–1.591), and prolonged prothrombin time (HR, 1.223; 95% CI, 1.052–1.423).
Conclusions
In a 16-year study of patients with chronic HBV infection and decompensated cirrhosis treated with nucleos(t)ide analogues, a baseline flare of hepatitis was associated independently with better long-term (≥3 mo) outcomes than no flare.